Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Urothelial Cancer/Enfortumab Vedotin

Andrea Necchi

MD

🏢Vita-Salute San Raffaele University🌐Italy

Head, Bladder Cancer Unit

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Andrea Necchi is a leading Italian urologic oncologist advancing neoadjuvant immunotherapy and ADC strategies for muscle-invasive bladder cancer. He has been a key investigator in enfortumab vedotin trials and has contributed to novel perioperative treatment approaches. His research integrates molecular profiling with clinical trial design to optimize patient outcomes.

Share:

🧪Research Fields 研究领域

Urothelial cancer
Neoadjuvant therapy
Enfortumab vedotin
Immunotherapy
Muscle-invasive bladder cancer

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrea Necchi 的研究动态

Follow Andrea Necchi's research updates

留下邮箱,当我们发布与 Andrea Necchi(Vita-Salute San Raffaele University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment